The six-month safety and efficacy data is in for the Pfizer vax. While we all await the larger readout from the full length of the phase III trials (due in 2023) this interim result is a much-needed peek at the trials.

Want to hear Chris's unfiltered thoughts? Click here for Part 2: https://www.peakprosperity.com/down-the-pfizer-data-rabbit-hole/